Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Serotoninergic syndrome is characterized by an excess of serotonin in the central nervous system, associated with the use of various agents, including selective serotonin reuptake inhibitors (SSRIs).
Biomarker and diagnostic research for serotonin syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for serotonin syndrome.
189 publications have been identified in PubMed for serotonin syndrome. Kisho has analyzed 124 by research type. Research spans Case Report / Case Series (46%), Review / Meta-Analysis (23%), and Epidemiology / Natural History (15%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 57 | 46% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 3:03 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
29 |
23% |
Disease patterns and progression | 19 | 15% |
Other research | 8 | 6% |
Laboratory research | 7 | 6% |
Clinical study results | 3 | 2% |
Testing and diagnosis research | 1 | 1% |
Wang H (2026). [PMID: 41248860](https://pubmed.ncbi.nlm.nih.gov/41248860/). *J Affect Disord*. [Epidemiology / Natural History]
Zhang J (2026). [PMID: 41971097](https://pubmed.ncbi.nlm.nih.gov/41971097/). *Front Pharmacol*. [Epidemiology / Natural History]
Căuș MN (2026). [PMID: 41901246](https://pubmed.ncbi.nlm.nih.gov/41901246/). *Pharmaceuticals (Basel)*. [Review / Meta-Analysis]
Toste A (2026). [PMID: 41690768](https://pubmed.ncbi.nlm.nih.gov/41690768/). *Pract Neurol*. [Case Report / Case Series]
Brown O (2026). [PMID: 41589868](https://pubmed.ncbi.nlm.nih.gov/41589868/). *Urogynecology (Phila)*. [Epidemiology / Natural History]
Wen Z (2026). [PMID: 41628752](https://pubmed.ncbi.nlm.nih.gov/41628752/). *J Affect Disord*. [Epidemiology / Natural History]
Nagamine T (2026). [PMID: 41444207](https://pubmed.ncbi.nlm.nih.gov/41444207/). *Expert Opin Drug Metab Toxicol*. [Other]
Jan A (2026). [PMID: 42128723](https://pubmed.ncbi.nlm.nih.gov/42128723/). *Am J Geriatr Psychiatry*. [Other]
Liu L (2026). [PMID: 41652380](https://pubmed.ncbi.nlm.nih.gov/41652380/). *BMC Psychiatry*. [Case Report / Case Series]
Moore JC (2026). [PMID: 41944631](https://pubmed.ncbi.nlm.nih.gov/41944631/). *Retin Cases Brief Rep*. [Case Report / Case Series]